Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Journal of Drug Targeting|April 10, 2018
Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft modelsLin Yu, Yuqin Yao, Yuxi Wang, et al.Journal of Proteome Research|June 24, 2010
Proteomic analysis of interstitial fluid in bone marrow identified that peroxiredoxin 2 regulates H(2)O(2) level of bone marrow during agingWei Wang, Lantu Gou, Gang Xie, et al.Journal of Cachexia, Sarcopenia and Muscle|August 6, 2016
Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signallingXiangzheng Chen, Yangping Wu, Tinghan Yang, et al.Electrophoresis|July 9, 2011
Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15Yuqin Yao, Jiong Li, Zejun Lu, et al.European Journal of Medicinal Chemistry|July 15, 2018
Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding siteQinhuai Lai, Yuxi Wang, Ruixue Wang, et al.Cancer Science|July 7, 2009
Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic geneZhu Yuan, Huanyi Liu, Fei Yan, et al.Molecular & Cellular Proteomics : MCP|May 7, 2008
Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinomaZhi Wang, Lu Jiang, Canhua Huang, et al.Oncoimmunology|June 10, 2026
FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activationShuang Liu, Ziqing Ren, Yongyan Tu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 7, 2015
Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugatesYuqin Yao, Lin Yu, Xiaolan Su, et al.Frontiers in Cell and Developmental Biology|July 26, 2021
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal CarcinomaYuyin Fu, Yujia Peng, Shengyan Zhao, et al.Pageof 5